Table 2 Study outcomes for MIST trial
| Â | Numerator | Denominator |
|---|---|---|
Primary outcome | ||
 Preterm live birth | Live births <37 weeks of gestation | All live births |
Secondary outcomes | ||
 Preterm birth and late miscarriage | Live births (28 to <37 weeks) | All birth outcomes ≥ 20 weeks |
Stillbirth (28 to <37 weeks) | ||
Late Miscarriage (20 to <28 weeks) | ||
 Late miscarriage rate | All spontaneous abortion/miscarriage (non-therapeutic abortions) occurring between 20 to <28 weeks | All birth outcomes ≥20 weeks |
 Stillbirth rate | Stillbirth (≥28 weeks) and no signs of life | All live births and stillbirths ≥28 weeks |
 Perinatal mortality rate | Stillbirth + early neonatal death (birth to 7 days) | All live births and stillbirths ≥28 weeks |
 Neonatal mortality rate | Neonatal death (birth to 28 days) | Live births |
 Early onset sepsis | Very severe disease by current IMCI guidelines on any day in first week of life | Live births |